AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Brivaracetam 100 Mg ;

12 registrations across 1 African market— 12 active

Markets with Brivaracetam 100 Mg ;

Recent registrations

Brand / ProductMarketHolderStatusExpires
Brivasizur 100 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Pilebriva 100 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Andolepsy 100 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Cetabrivara 100mg
Film Coated Tablets
🇪🇬EgyptRIVA PHARMAactive
Brivafutal 100 mg
Film Coated Tablets
🇪🇬EgyptFUTURE PHARMACEUTICAL INDUSTRIES-EGYPTactive
Brivasizur 100 mg
Film Coated Tablets
🇪🇬EgyptGlobal Pharmaceutical Industriesactive
Pilebriva 100 mg
Film Coated Tablets
🇪🇬EgyptHikma Pharmaceuticals industriesactive
Varocetam 100 mg
Film Coated Tablets
🇪🇬EgyptGypto Pharma for Pharmaceutical Manufacturing and Trading - GYPTOactive
Andolepsy 100 mg
Film Coated Tablets
🇪🇬Egyptal andalous for pharmaceutical industriesactive
Convarsiotam
Film Coated Tablets
🇪🇬EgyptMarcyrl pharmaceutical industries - MPIactive
Convulsobriv 100 mg
Film Coated Tablets
🇪🇬Egyptphoenix overseas for pharmaceuticalsactive
Kativarox 100 mg
Film Coated Tablets
🇪🇬EgyptApex pharmaactive

Brivaracetam 100 Mg ; in Africa — Regulatory Overview

Brivaracetam 100 Mg ; is registered across 1 African markets with 12 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Egypt. AfricaRegulatory refreshes this data daily from official government sources.

Of the 12 registrations, 12 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.